These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23071850)

  • 1. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
    Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
    PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.
    Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
    Antimicrob Agents Chemother; 2012 Feb; 56(2):697-702. PubMed ID: 22106221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
    Chauffour A; Morel F; Reibel F; Petrella S; Mayer C; Cambau E; Aubry A
    Clin Microbiol Infect; 2021 Nov; 27(11):1601-1612. PubMed ID: 34265461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
    Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
    Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae.
    Park JH; Yamaguchi T; Ouchi Y; Koide K; Mori S; Kim H; Mukai T; Nakajima C; Suzuki Y
    J Infect Chemother; 2020 Apr; 26(4):335-342. PubMed ID: 31839561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Quinolones Carrying New R1 Group with
    Park JH; Yamaguchi T; Ouchi Y; Koide K; Pachanon R; Chizimu JY; Mori S; Kim H; Mukai T; Nakajima C; Suzuki Y
    Microb Drug Resist; 2021 Dec; 27(12):1616-1623. PubMed ID: 34077282
    [No Abstract]   [Full Text] [Related]  

  • 9. Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
    Matrat S; Cambau E; Jarlier V; Aubry A
    Antimicrob Agents Chemother; 2008 Feb; 52(2):745-7. PubMed ID: 18070975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluoroquinolone resistance associated mutation in gyrA Affects DNA supercoiling in Campylobacter jejuni.
    Han J; Wang Y; Sahin O; Shen Z; Guo B; Shen J; Zhang Q
    Front Cell Infect Microbiol; 2012; 2():21. PubMed ID: 22919613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
    Mayer C; Takiff H
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0009-2013. PubMed ID: 26104201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
    Ouchi Y; Mukai T; Koide K; Yamaguchi T; Park JH; Kim H; Yokoyama K; Tamaru A; Gordon SV; Nakajima C; Suzuki Y
    Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Veziris N; Matrat S; Bouige A; Ferrand H; Sougakoff W; Mayer C; Aubry A
    J Antimicrob Chemother; 2016 Sep; 71(9):2428-31. PubMed ID: 27234461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Bernard C; Veziris N; Brossier F; Sougakoff W; Jarlier V; Robert J; Aubry A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1519-24. PubMed ID: 25534742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance-associated amino acid substitutions affect enzymatic activity of Mycobacterium leprae DNA gyrase.
    Yamaguchi T; Yokoyama K; Nakajima C; Suzuki Y
    Biosci Biotechnol Biochem; 2017 Jul; 81(7):1343-1347. PubMed ID: 28417702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    Ehrmann E; Jolivet-Gougeon A; Bonnaure-Mallet M; Fosse T
    J Antimicrob Chemother; 2017 Aug; 72(8):2208-2212. PubMed ID: 28453633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
    Kim H; Nakajima C; Yokoyama K; Rahim Z; Kim YU; Oguri H; Suzuki Y
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis.
    Yoshida M; Nakata N; Miyamoto Y; Fukano H; Ato M; Hoshino Y
    FEMS Microbiol Lett; 2018 Dec; 365(23):. PubMed ID: 30418577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.